Bastiaan Sallevelt

184 CHAPTER 2.3 Table SI2.2. Continued. Drug Class (ATC) ATC Code Description (ATC) STOPP Criteria START Criteria Comments Bisphosphonates, combinations M05BB01 etidronic acid and calcium, sequential E2, E3 Bisphosphonates, combinations M05BB02 risedronic acid and calcium, sequential E2, E3 Bisphosphonates, combinations M05BB03 alendronic acid and colecalciferol E2, E3, E5 Bisphosphonates, combinations M05BB04 risedronic acid, calcium and colecalciferol, sequential E2, E3, E5 Bisphosphonates, combinations M05BB05 alendronic acid, calcium and colecalciferol, sequential E2, E3, E5 Bisphosphonates, combinations M05BB06 alendronic acid and alfacalcidol, sequential E2, E3, E5 Bisphosphonates, combinations M05BB07 risedronic acid and colecalciferol E2, E3, E5 Bisphosphonates, combinations M05BB08 zoledronic acid, calcium and colecalciferol, sequential E2, E3, E5 Drugs affecting bone structure and mineralization M05B Drugs affecting bone structure and mineralization E4 Drugs affecting bone structure and mineralization H05AA02 Teriparatide E4 Drugs used in benign prostatic hypertrophy G04CA alpha-adrenoreceptor antagonists I2, K3 G1 Antiadrenergic agents, peripherally acting C02CA alpha-adrenoreceptor antagonists I2, K3

RkJQdWJsaXNoZXIy MTk4NDMw